|
Suppliers for CAS
783355-60-2
|
Properties | | CAS |
783355-60-2 | | Formula |
C21H23N3O5 |
|
|
6 Registered suppliers
Amadis Chemical Company Limited
P.R.China
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C21H23N3O5
Molecular Weight: 397.42442
Aea.ltd
P.R.China
Molecular Formula: C21H23N3O5
Molecular Weight: 397.42442
BOC Sciences
USA
Description : Abexinostat, also known as PCI-24781 or CRA-024781, is a novel, broad-spectrum hydroxamic acid-based inhibitor of histone deacetylase (HDAC) with potential antineoplastic activity. Abexinostat inhibits several isoforms of HDAC, resulting in an accumulation of highly acetylated histones, followed by the induction of chromatin remodeling. - Molecular Weight :397.431
- Purity :98%
Molecular Formula : C21H23N3O5 Canonical SMILES : CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO
InChI :
InChI=1S/C21H23N3O5/c1-24(2)13-17-16-5-3-4-6-18(16)29-19(17)21(26)22-11-12-28-15-9-7-14(8-10-15)20(25)23-27/h3-10,27H,11-13H2,1-2H3,(H,22,26)(H,23,25)
InChIKey :
MAUCONCHVWBMHK-UHFFFAOYSA-N
Appearance :
white solid powder
Synonyms :
CRA-024781; CRA 024781; CRA024781; PCI-24781; PCI24781; PCI 24781
More details are to be found here
Chemos GmbH & Co. KG
Germany
Description : Abexinostat, also known as PCI-24781 or CRA-024781, is a novel, broad-spectrum hydroxamic acid-based inhibitor of histone deacetylase (HDAC) with potential antineoplastic activity. Abexinostat inhibits several isoforms of HDAC, resulting in an accumulation of highly acetylated histones, followed by the induction of chromatin remodeling. - Molecular Weight :397.431
- Purity :98%
Molecular Formula : C21H23N3O5 Canonical SMILES : CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO
InChI :
InChI=1S/C21H23N3O5/c1-24(2)13-17-16-5-3-4-6-18(16)29-19(17)21(26)22-11-12-28-15-9-7-14(8-10-15)20(25)23-27/h3-10,27H,11-13H2,1-2H3,(H,22,26)(H,23,25)
InChIKey :
MAUCONCHVWBMHK-UHFFFAOYSA-N
Appearance :
white solid powder
Synonyms :
CRA-024781; CRA 024781; CRA024781; PCI-24781; PCI24781; PCI 24781
More details are to be found here
Santa Cruz Biotechnology, Inc.
USA
Description : Abexinostat, also known as PCI-24781 or CRA-024781, is a novel, broad-spectrum hydroxamic acid-based inhibitor of histone deacetylase (HDAC) with potential antineoplastic activity. Abexinostat inhibits several isoforms of HDAC, resulting in an accumulation of highly acetylated histones, followed by the induction of chromatin remodeling. - Molecular Weight :397.431
- Purity :98%
Molecular Formula : C21H23N3O5 Canonical SMILES : CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO
InChI :
InChI=1S/C21H23N3O5/c1-24(2)13-17-16-5-3-4-6-18(16)29-19(17)21(26)22-11-12-28-15-9-7-14(8-10-15)20(25)23-27/h3-10,27H,11-13H2,1-2H3,(H,22,26)(H,23,25)
InChIKey :
MAUCONCHVWBMHK-UHFFFAOYSA-N
Appearance :
white solid powder
Synonyms :
CRA-024781; CRA 024781; CRA024781; PCI-24781; PCI24781; PCI 24781
More details are to be found here
|
details
details